MagIA diagnostics announces that Mr. Philippe Jacon will be joining its Board

Mr. Jacon will be joining MagIA diagnostics’ board after a long career in the in-vitro diagnostics business. In his previous roles, Philippe JACON was the Executive Vice President, Emerging Markets, SVP Global Access at CEPHEID from 2013…

Une R&D collaborative école/entreprise adaptée aux projets de DM connectés

  Lors de la dernière édition de Medi'Nov, le directeur du transfert de technologie de l'école d'ingénieurs Grenoble INP - Esisar est venu faire le point sur le "Projet Industriel" dans le cadre des dispositifs médicaux : un…

IMeBIO Expands to South America with Local Partner BioSafe: Advancing Biosafety in the Region

As part of its expansion strategy to the South American Market, IMeBIO, a global provider of mobile/modular biocontainment laboratory solutions had the opportunity to announce its strategic partnership with BioSafe Brasil, a leader local biosafety…

BIOTEM implements new industrial unit dedicated to development and production of immunoassays

,
PRESS RELEASE - June, 20, 2022 - Apprieu (Grenoble) Leader in development of high-quality custom antibodies, BIOTEM is boosting expertise in immunoassays and increasing kit production capacity tenfold   Project partly supported…

As SYNTHELIS and PEACCEL have signed a strategic partnership to offer their clients a one-stop shop combining Artificial Intelligence (AI) and Cell-Free lead expression for accelerated drug discovery

,
PRESS RELEASE - 12th April 2022- La Tronche   As of 12th April 2022, PEACCEL and SYNTHELIS combine their know-how and thus capitalize on their respective technologies in developing a joint offer, to respond to the needs of their customers…

Microlight 3D releases new range of resins for 3D microprinting

,
PRESS RELEASE - June 14th- Grenoble Eight new resins widen scope for mechanical meta-materials and life sciences researchers to 3D print, at micro scale, complex objects with novel properties Grenoble, France, June 14, 2022 – Microlight3D,…

FDA Grants Breakthrough Device Designation to Remedee Labs for its groundbreaking endorphin stimulation solution for the management of Fibromyalgia

,
Paris – May 12, 2022 – On World Fibromyalgia Awareness Day (May 12), the French startup Remedee Labs is announcing that the FDA has granted Breakthrough Device Designation to its endorphin stimulator for fibromyalgia patients. The FDA’s…

CEA: a key player in the field of Organ-on-Chip

,
On February 23rd  and 24st, 2022, the plenary meeting for the structuring of the OoC sector in France was held in Paris, organized by BioValley France (BVF), Institut Curie/IPGG and the CEA-IRIG (Interdisciplinary Research Institute of Grenoble)…

EVEON is accelerating its development for the benefit of pharmaceutical companies and patient treatment adherence

,
Grenoble, March 8, 2022 – EVEON, designer and manufacturer of medical devices for the preparation and delivery of drugs, made numerous project achievements in 2021 in collaboration with pharmaceutical companies. It looks like another promising…

IMABGEN Project, an innovative platform in immunotherapies

,
Lyon, December 16, 2021 The IMABGEN Platform project, an innovative service for the generation of therapeutic antibodies carried by BIOTEM, CALIXAR and the CNRS / Université Claude Bernard Lyon 1, is one of the laureates of the ‘‘R&D…